Recently, SGK1 [27,28,29,30,31] has also been demonstrated to be involved in cancer as the main effector of the aberrant deregulation of SRC kinase signaling [32], a major driver of cancer development and resistance to therapy [33,34,35,36,37,38]. The gene discussed is SGK1; the disease is cancer.